Research

We have so far developed methods to evaluate and select the performance of a large number of biopharmaceutical candidate molecules, far in excess of one million types, in a batch, using supercomputer-based structural calculations and molecular display cells by genetic recombination. While advancing the sophistication of these technologies, we are currently conducting two research projects: (1) pioneering next-generation biopharmaceutical design technologies and (2) developing ultra-sensitive detection probes for tumours.